None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Diagnosed with spinal diseases (KCD M and S codes) 2) Dominant pain Numeric Rating Scale (NRS) of 5 or higher due to spinal disease 3) Outpatients or inpatients scheduled to receive ultrasound-guided pharmacopuncture based on clinical judgment (The decision to perform ultrasound-guided pharmacopuncture is determined by the clinician's medical judgment, not for the purpose of the study, and patients are scheduled to undergo ultrasound-guided pharmacopuncture according to their treatment plan) 4) Aged 19 years to under 70 years 5) Voluntarily signed the written informed consent form
Exclusion criteria
Exclusion criteria: 1) Difficulty in providing written informed consent 2) Pregnant, planning to become pregnant, or lactating women 3) Inappropriate for the study based on the investigator's judgment (e.g., severe diseases such as cancer that could interfere with the interpretation of treatment effects or results)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Pain Numeric Rating Scale (NRS) for spinal pain from baseline to week 4 | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence and number of Adverse Events (AE);Functional disability scales (Neck Disability Index (NDI) or Oswestry Disability Index (ODI));Quality of life assessment scale (EQ-5D-5L);Patient Satisfaction;Pain Numeric Rating Scale (NRS) | — |
Countries
Korea, Republic of
Contacts
Jaseng Medical Foundation